Maria Siiskonen, Rydvikha Govender, Johan Malmqvist, Staffan Folestad
{"title":"Modelling the cost-benefit impact of integrated product modularisation and postponement in the supply chain for pharmaceutical mass customisation","authors":"Maria Siiskonen, Rydvikha Govender, Johan Malmqvist, Staffan Folestad","doi":"10.1080/09544828.2023.2266330","DOIUrl":null,"url":null,"abstract":"Realisation of pharmaceutical product and production systems capable of delivering product customisation cost-effectively is essential for adding value to patients and society through improved tailoring of therapies to individuals relative to current mass-produced products. To address the continued lack of evidence-based system solutions, this study presents a holistic design framework and a novel computational platform for enabling design explorations of integrated pharmaceutical product and supply chain (SC) reconfiguration. The design and modelling framework developed herein takes an end-to-end SC perspective, adapts the mass customisation strategies of product modularisation and postponement, and demonstrates case study simulations based on real-life therapy and SC archetypes. The cost-effectiveness assessment with the derived integrated systems computational platform confirm that product modularisation drives patient benefit through variety provision and that postponement drives cost reduction in an end-to-end SC. A novel insight is therefore that both product modularisation and postponement, in an integrated manner, are required for maximising cost-effective customisation. Moreover, the computational simulations, founded and modelled on real-life scenarios, provide design requirements for reconfigurable product and SC systems in a pharmaceutical context. In all, these findings are imperative for providing guidance on integrated pharmaceutical product and production systems design and mass customisation/ mass personalisation/mass individualisation realisation.","PeriodicalId":50207,"journal":{"name":"Journal of Engineering Design","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Engineering Design","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/09544828.2023.2266330","RegionNum":2,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Realisation of pharmaceutical product and production systems capable of delivering product customisation cost-effectively is essential for adding value to patients and society through improved tailoring of therapies to individuals relative to current mass-produced products. To address the continued lack of evidence-based system solutions, this study presents a holistic design framework and a novel computational platform for enabling design explorations of integrated pharmaceutical product and supply chain (SC) reconfiguration. The design and modelling framework developed herein takes an end-to-end SC perspective, adapts the mass customisation strategies of product modularisation and postponement, and demonstrates case study simulations based on real-life therapy and SC archetypes. The cost-effectiveness assessment with the derived integrated systems computational platform confirm that product modularisation drives patient benefit through variety provision and that postponement drives cost reduction in an end-to-end SC. A novel insight is therefore that both product modularisation and postponement, in an integrated manner, are required for maximising cost-effective customisation. Moreover, the computational simulations, founded and modelled on real-life scenarios, provide design requirements for reconfigurable product and SC systems in a pharmaceutical context. In all, these findings are imperative for providing guidance on integrated pharmaceutical product and production systems design and mass customisation/ mass personalisation/mass individualisation realisation.
期刊介绍:
The Journal of Engineering Design is a leading international publication that provides an essential forum for dialogue on important issues across all disciplines and aspects of the design of engineered products and systems. The Journal publishes pioneering, contemporary, best industrial practice as well as authoritative research, studies and review papers on the underlying principles of design, its management, practice, techniques and methodologies, rather than specific domain applications.
We welcome papers that examine the following topics:
Engineering design aesthetics, style and form-
Big data analytics in engineering design-
Collaborative design in engineering-
Engineering concept design-
Creativity and innovation in engineering-
Engineering design architectures-
Design costing in engineering
Design education and pedagogy in engineering-
Engineering design for X, e.g. manufacturability, assembly, environment, sustainability-
Engineering design management-
Design risk and uncertainty in engineering-
Engineering design theory and methodology-
Designing product platforms, modularity and reuse in engineering-
Emotive design, e.g. Kansei engineering-
Ergonomics, styling and the design process-
Evolutionary design activity in engineering (product improvement & refinement)-
Global and distributed engineering design-
Inclusive design and assistive engineering technology-
Engineering industrial design and total design-
Integrated engineering design development-
Knowledge and information management in engineering-
Engineering maintainability, sustainability, safety and standards-
Multi, inter and trans disciplinary engineering design-
New engineering product design and development-
Engineering product introduction process[...]